Status:
COMPLETED
Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Conditions:
Obesity
Insulin Resistance
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate if a supplement containing omega-3 long chain polyunsaturated fatty acids for three months reduce obesity and insulin resistance to obese adolescents if admini...
Detailed Description
Background: In 2006, the prevalence of overweight and obesity combined in scholar and adolescents in Mexico was 26% and 31% respectively, which represents more than double of that reported in year 200...
Eligibility Criteria
Inclusion
- Age between 12 and 18 years,
- Male and female
- Body mass Index (BMI) above the 95 percentile of the National Center for Health Statistics (NCHS) reference
- Informed consent form signed by both parents or legal guardian.
Exclusion
- Those diagnosed as with Diabetes Mellitus Type 2 (DMT2), Cardiovascular disease (CVD) or kidney disease
- Those who are allergic to fish.
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT01456221
Start Date
July 1 2012
End Date
January 1 2017
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit or research in Medical Nutrition, Pediatric Hospital CMN "Siglo XXI", Instituto Mexicano del Seguro Social
Mexico City, Mexico, 06720